(Press-News.org) NRG Oncology (NRG), a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced two new Vice-Chairs to co-lead the NRG Patient Advocate Committee (PAC) alongside the current PAC Committee Chair, Dorothy Erlanger.
Marlyn Molero, was appointed as Vice-Chair of the NRG PAC. Marlyn is a clinical researcher in the oncology area with Commonspirit Research Institute as well as a Spanish interpreter at Vituity. Marlyn brings a unique perspective to the NRG PAC leadership as she previously obtained her Obstetrics and Gynecologic degree from the Universidad Central de Venezuela where she practiced for 14 years before moving to the United States. She remains a collaborative professor of OB/GYN, with an emphasis on gynecologic and surgical techniques, at the Perez Carreno Hospital/Central University of Venezuela where she previously served as Vice-Chair of their Academic Committee. Marlyn is in the process of cementing her qualifications in the U.S. healthcare system in order to obtain her medical license. She is driven by a personal mission to utilize her experiences in the U.S. and Venezuelan healthcare landscapes to shape a better pathway for cancer care, especially for underserved and diverse populations. Marlyn specializes in ensuring clear and compassionate communications across all levels of patient care and research. Outside of her day-to-day profession, Marlyn also works as a Spanish interpreter in the emergency room of a community hospital on the central coast of California. In addition to her involvement on the NRG PAC committee, Marlyn is also a member of the NRG Gynecologic Oncology Committee.
Tambre Leighn, was also appointed as Vice-Chair of the NRG PAC. Tambre is a highly regarded consultant, trainer, and speaker in the healthcare industry. She holds a Master of Communications from Loyola Marymount University and is a Certified Professional Coach.
Tambre’s work as an advocate and professionally through her company, Well Beyond Ordinary, is the legacy of her late husband who died of Hodgkin’s disease when he was only 37 years old. Her focus is on improving patient communication, engagement, and adherence through innovative coaching-based solutions. In 2018, Tambre’s Patient Adherence Training Program was a semi-finalist in the Astellas Innovative Patient Support Solutions C3 Competition.
In addition to her patient-focused work, Tambre consults on clinical trials and provides leadership and communication training to specialty pharmacies, nurse call centers, and healthcare professionals. She has worked for organizations such as Stanford Health Care, Genentech, Amazon Health, Keep A Breast Foundation, and Weill Cornell. She also chaired the 7th Annual Patient Adherence and Advocacy Summit. Most recently, Tambre presented a poster, “Ask Me!: Transforming Patient Communication to Improve Enrollment & Adherence in Clinical Trials and Cancer Care” at the 2024 American Association for Cancer Research Conference.
Tambre has been a highly engaged advocate for over twelve years. She was a Peer Stakeholder Grant Reviewer for the American Cancer Society’s New Drug Discovery Committee and an advocate for NCI’s Lymphoma Steering Committee. Since 2017, she’s been an advocate with Knight Cancer Institute at OHSU and is part of their international project, ACED, focused on early cancer detection. At NRG, Tambre is also actively involved in the organization’s Cancer Care Delivery and Research (CCDR) Committee as well as the Communications Committee.
NRG is incredibly grateful for the many years of service and several contributions of outgoing committee Vice-Chairs, Tom Simon and Pat Halpin Murphy. Tom and Pat’s leadership, guidance, and experience helped NRG’s PAC grow roots within the organization’s infrastructure and prosper into the committee it is today.
About NRG Oncology
NRG Oncology conducts practice-changing, multi-institutional clinical and translational research to improve the lives of patients with cancer. Founded in 2012, NRG Oncology is a Pennsylvania-based nonprofit corporation that integrates the research of the legacy National Surgical Adjuvant Breast and Bowel Project (NSABP), Radiation Therapy Oncology Group (RTOG), and Gynecologic Oncology Group (GOG) programs. The research network seeks to carry out clinical trials with emphases on gender-specific malignancies, including gynecologic, breast, and prostate cancers, and on localized or locally advanced cancers of all types. NRG Oncology’s extensive research organization comprises multidisciplinary investigators, including medical oncologists, radiation oncologists, surgeons, physicists, pathologists, and statisticians, and encompasses more than 1,300 research sites located world-wide with predominance in the United States and Canada. NRG Oncology is supported primarily through grants from the National Cancer Institute (NCI) and is one of five research groups in the NCI’s National Clinical Trials Network.
www.nrgoncology.org
END
NRG Oncology appoints new vice-chairs for their patient advocate committee
2024-05-28
ELSE PRESS RELEASES FROM THIS DATE:
Why do Dyeing poison frogs tap dance?
2024-05-28
The toe tapping behavior of various amphibians has long attracted attention from researchers and pet owners. Despite being widely documented, the underlying functional role is poorly understood. In a new paper, researchers demonstrate that Dyeing poison frogs modulate their taps based on specific stimuli.
Dyeing poison frogs, Dendrobates tinctorius, have been shown to tap their posterior toes in response to a range of prey sizes, from small fruit flies to large crickets. In the present study, ...
UC Irvine study reveals circadian clock can be leveraged to enhance cancer immunotherapy
2024-05-28
Irvine, Calif., May 28, 2024 — A multidisciplinary research team at the University of California, Irvine has revealed that the circadian clock – the biological pacemaker that governs daily rhythms in physiological processes, including immune functions – can be leveraged to enhance the efficacy of checkpoint inhibitor cancer therapy. Checkpoint inhibitors block different proteins from binding to tumor cells, allowing the immune system’s T cells to kill the tumor.
The study, published online ...
Cell-targeting technology allows researchers to isolate neuronal subpopulations and link them to behavioral states
2024-05-28
(MEMPHIS, Tenn. – May 27, 2024) As gene sequencing technologies become more powerful, our understanding of cellular diversity has grown in parallel. This led scientists at St. Jude Children’s Research Hospital to create a tool to improve the ease and accuracy with which investigators can study specific subpopulations of cells. The tool, named Conditional Viral Expression by Ribozyme Guided Degradation (ConVERGD), allows researchers to specifically access these subgroups of cells and precisely manipulate ...
When should you neuter or spay your dog?
2024-05-28
Researchers at the University of California, Davis, have updated their guidelines on when to neuter 40 popular dog varieties by breed and sex. Their recent paper in Frontiers in Veterinary Science adds five breeds to a line of research that began in 2013 with a study that suggested that early neutering of golden retrievers puts them at increased risk of joint diseases and certain cancers.
That initial study set off a flurry of debate about the best age to neuter other popular breeds. Professors Lynette and Benjamin Hart of the School of Veterinary Medicine, the study’s lead authors, set out to add more breed studies by examining more than a decade ...
Is it a sound of music…or of speech? Scientists uncover how our brains try to tell the difference
2024-05-28
Music and speech are among the most frequent types of sounds we hear. But how do we identify what we think are differences between the two?
An international team of researchers mapped out this process through a series of experiments—yielding insights that offer a potential means to optimize therapeutic programs that use music to regain the ability to speak in addressing aphasia. This language disorder afflicts more than 1 in 300 Americans each year, including Wendy Williams and Bruce Willis.
“Although music and speech are different in many ways, ranging from pitch to timbre to sound texture, ...
New test rapidly diagnoses Toxoplasma infections and reduces false positives
2024-05-28
An inexpensive, accurate test that detects infections with the parasite Toxoplasma gondii can provide results within 30 minutes from a finger-prick in a doctor’s office or within an hour from a small blood sample tested in a local medical laboratory. The new test can also identify false positives in other types of commercial diagnostic tests for toxoplasmosis, providing swift reassurance to uninfected pregnant women and their doctors and facilitating timely interventions to protect a fetus against toxoplasmosis in acutely infected pregnant mothers.
These findings appear in a study, led by toxoplasmosis specialist Rima McLeod, MD, ...
Overlooked lipid connected to ancient cellular pathway with links to cancer
2024-05-28
Within the family of cell membrane lipids known as phosphoinositides and the kinase enzymes that regulate them, phosphoinositide 3-kinases (PI3Ks) have been cast in a starring role as scientists study their involvement in cancer, diabetes and many cellular activities.
The presence of PI3Ks in the scientific limelight has overshadowed other members of this lipid enzyme family, including phosphatidylinositol-5-phosphate 4-kinases (PI5P4Ks). Brooke Emerling, Ph.D., co-director of, and associate professor in, the Cancer Metabolism and Microenvironment Program at Sanford Burnham Prebys, is contributing to a revival of interest in this underappreciated set of enzymes.
Emerling and team have ...
Text reminders help connect health care workers to care and improve their mental health
2024-05-28
Health care workers have reported spikes in feeling burnt out in the time since the COVID-19 pandemic began, with nearly half saying it took a toll in 2022 compared to 32 percent in 2018. But a new study shows that easy-to-use and accessible platforms may help reverse this trend. Regular, automated text message reminders connecting staff to a mental health platform called “Cobalt,” drove significant improvements in both depression and anxiety scores among employees, according to a new JAMA Network Open study from the Perelman School of Medicine at the University of Pennsylvania.
“What we found shows ...
Optimal cancer-killing t cells discovered
2024-05-28
A team of cancer researchers, led by the University of Houston, has discovered a new subset of T cells that may improve the outcome for patients treated with T-cell therapies.
T cell-based immunotherapy has tremendous value to fight, and often eliminate, cancer. The strategy activates a patient’s immune system and engineers a patient’s own T cells to recognize, attack and kill cancer cells. In this way, the body’s own T cells become living drugs.
While T-cell immunotherapy has revolutionized cancer treatment, there is still much to learn. Unfortunately, not all patients ...
Wind farms are cheaper than you think – and could have prevented Fukushima, says global review
2024-05-28
Offshore wind could have prevented the Fukushima disaster, according to a review of wind energy led by the University of Surrey.
The researchers found that offshore turbines could have averted the 2011 nuclear disaster in Japan by keeping the cooling systems running and avoiding meltdown. The team also found that wind farms are not as vulnerable to earthquakes.
Suby Bhattacharya, Professor of Geomechanics at the University of Surrey’s Department of Civil and Environmental Engineering, said:
“Wind power gives us plentiful clean energy – now we know that it could also make other facilities safer and more reliable. The global review finds ...